According to GlobalData’s medical device pipeline database, 329 Interventional Neuroradiology devices are in various stages of development globally. GlobalData’s report Interventional Neuroradiology provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 240 are in active development, while the remaining 92 are in an inactive stage of development. There are 131 products in the early stages of development, and the remaining 109 are in the late stages of development.
Neurovascular embolization devices, neurovascular accessory devices, neurovascular coiling assist devices, neurovascular thrombectomy devices and intracranial stents are the segments covered under this category.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Interventional Neuroradiology pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Interventional Neuroradiology devices. Overall, most of these Interventional Neuroradiology pipeline devices are being developed by private entities.
Key players involved in the active development of Interventional Neuroradiology include Zylox-Tonbridge Medical Technology, HeMo Bioengineering, Peijia Medical, Shanghai HeartCare Medical Technology, MicroPort NeuroTech, OrbusNeich, Vesalio, PhotoThera, NeuroVasc Technologies and University of California Los Angeles.
For a complete picture of the developmental pipeline for Interventional Neuroradiology devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.